Lazard Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-54,015
Closed -$1.54M 1955
2026
Q1
$1.54M Buy
54,015
+4,296
+9% +$147K ﹤0.01% 1030
2025
Q4
$1.97M Buy
49,719
+2,878
+6% +$106K ﹤0.01% 866
2025
Q3
$1.65M Buy
46,841
+3,830
+9% +$132K ﹤0.01% 933
2025
Q2
$1.41M Buy
+43,011
New +$1.4M ﹤0.01% 1146
2024
Q3
Sell
-2,940
Closed -$66K 2263
2024
Q2
$66K Buy
2,940
+1,530
+109% +$35.3K ﹤0.01% 1874
2024
Q1
$42K Sell
1,410
-2,250
-61% -$75.4K ﹤0.01% 1749
2023
Q4
$130K Buy
3,660
+126
+4% +$4.69K ﹤0.01% 1552
2023
Q3
$154K Buy
3,534
+1,716
+94% +$83.7K ﹤0.01% 1470
2023
Q2
$89K Hold
1,818
﹤0.01% 1622
2023
Q1
$75K Hold
1,818
﹤0.01% 1639
2022
Q4
$80K Hold
1,818
﹤0.01% 1607
2022
Q3
$71K Buy
1,818
+416
+30% +$19K ﹤0.01% 1631
2022
Q2
$57K Buy
+1,402
New +$66.4K ﹤0.01% 1748
2021
Q4
Sell
-14,744
Closed -$1.02M 2282
2021
Q3
$1.02M Buy
+14,744
New +$1.13M ﹤0.01% 1058

Other funds holding ATRC

Lazard Asset Management's ATRC Position: Q2 2026 in Review

Lazard Asset Management sold out of AtriCure (ATRC) in Q2 2026, closing a stake of 54,015 shares — an estimated $1.54M sold.

Lazard Asset Management first reported a position in ATRC in Q3 2021 and held it in 14 quarters. The position peaked at $1.97M in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Lazard Asset Management reported no remaining AtriCure position as of Q2 2026 after selling out during the quarter.
  • Lazard Asset Management sold 54,015 AtriCure shares in Q2 2026, an estimated $1.54M.
  • Lazard Asset Management first reported a position in AtriCure in Q3 2021 and held it in 14 quarters.
  • Lazard Asset Management's AtriCure position peaked at $1.97M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.